0,895  0,006  Apoptosis agonist
0,843  0,004  Antiosteoporotic
0,838  0,002  NOS3 expression enhancer
0,836  0,002  Estrogen receptor alpha antagonist
0,835  0,002  Cystathionine beta-synthase inhibitor
0,820  0,004  Antioxidant
0,816  0,003  Estrogen antagonist
0,812  0,004  Free radical scavenger
0,804  0,005  Bone diseases treatment
0,792  0,010  Antineoplastic (breast cancer)
0,777  0,021  Alpha-glucosidase inhibitor
0,734  0,003  Topoisomerase II inhibitor
0,731  0,005  Amyloid beta aggregation inhibitor
0,724  0,003  Estrogen receptor beta antagonist
0,725  0,008  Prostate cancer treatment
0,716  0,010  Alzheimer's disease treatment
0,708  0,003  Estrogen agonist
0,701  0,005  Antimutagenic
0,692  0,005  UGT1A6 substrate
0,678  0,004  Skin whitener
0,697  0,024  Caspase 9 stimulant
0,674  0,006  Caspase 3 stimulant
0,670  0,008  UGT1A9 substrate
0,663  0,007  Nitric oxide antagonist
0,673  0,021  Antineoplastic (lung cancer)
0,669  0,037  Antiinflammatory
0,631  0,009  NOS2 expression inhibitor
0,617  0,012  Chemopreventive
0,605  0,002  Estrogen receptor beta agonist
0,605  0,018  Aldehyde oxidase inhibitor
0,599  0,018  Antiparkinsonian
0,585  0,005  Genotoxic
0,607  0,030  Transcription factor NF kappa B inhibitor
0,574  0,007  Vasodilator
0,592  0,029  Antidiabetic
0,592  0,029  Cyclophilin D inhibitor
0,575  0,013  AR expression inhibitor
0,561  0,004  Amylase inhibitor
0,569  0,014  Cardioprotectant
0,559  0,005  UGT1A3 substrate
0,556  0,004  Lipid peroxidase inhibitor
0,555  0,007  Antihypertriglyceridemic
0,561  0,016  CTGF expression inhibitor
0,552  0,009  UDP-glucuronosyltransferase substrate
0,531  0,007  P-glycoprotein inhibitor
0,526  0,004  Topoisomerase I inhibitor
0,524  0,004  UGT2B15 substrate
0,531  0,016  Apoptosis antagonist
0,535  0,024  Immunosuppressant
0,505  0,007  Monophenol monooxygenase inhibitor
0,534  0,038  TNF expression inhibitor
0,505  0,010  UGT1A1 substrate
0,496  0,003  Postmenopausal disorders treatment
0,526  0,035  Antileukemic
0,507  0,020  Cytostatic
0,504  0,019  NOS3 expression inhibitor
0,513  0,037  Antibacterial
0,490  0,020  Antineoplastic (glioma)
0,471  0,004  SULT1A3 substrate
0,490  0,024  Antineoplastic (cervical cancer)
0,502  0,035  Antineoplastic (colorectal cancer)
0,491  0,027  Antihypercholesterolemic
0,451  0,006  Sulfotransferase substrate
0,437  0,005  Acetylcholinesterase inhibitor
0,448  0,020  UGT2B4 substrate
0,464  0,037  Angiogenesis inhibitor
0,440  0,022  Hypoglycemic
0,455  0,038  CYP2C19 inhibitor
0,456  0,040  Antineoplastic (colon cancer)
0,433  0,024  Antiamyloidogenic
0,455  0,052  15-Lipoxygenase inhibitor
0,424  0,024  Antineoplastic (glioblastoma multiforme)
0,433  0,036  CYP2C19 substrate
0,408  0,012  Hepatoprotectant
0,431  0,037  Antifungal
0,441  0,054  Histamine release inhibitor
0,418  0,033  Lipoxygenase inhibitor
0,417  0,034  ICAM1 expression inhibitor
0,393  0,012  Melanin inhibitor
0,412  0,033  Chemoprotective
0,389  0,010  Cholinergic
0,388  0,015  Contraceptive
0,410  0,038  CYP1A2 substrate
0,400  0,028  DNA damaging
0,398  0,029  Proliferative diseases treatment
0,404  0,043  Hepatic disorders treatment
0,373  0,017  GST M1-1 substrate
0,360  0,005  Histone deacetylase class III inhibitor
0,395  0,042  Antimycobacterial
0,377  0,027  Antimitotic
0,382  0,034  Antiprotozoal (Leishmania)
0,373  0,025  Peroxidase inhibitor
0,365  0,021  5 Hydroxytryptamine uptake stimulant
0,352  0,008  Glutathione S-transferase substrate
0,348  0,005  Topoisomerase II alpha inhibitor
0,386  0,043  Antineoplastic (melanoma)
0,377  0,038  Antituberculosic
0,378  0,039  Cytotoxic
0,341  0,003  Estrogen receptor alpha agonist
0,397  0,063  GABA C receptor rho-3 antagonist
0,337  0,004  Creatine kinase inhibitor
0,337  0,007  UGT2B1 substrate
0,335  0,005  Histone deacetylase SIRT1 inhibitor
0,334  0,007  Antihemorrhagic
0,340  0,019  UGT2B7 substrate
0,361  0,041  Hypoxia-inducible factor 1 alpha inhibitor
0,366  0,048  Antineoplastic (brain cancer)
0,332  0,017  Antineoplastic (squamous cell carcinoma)
0,342  0,039  Antineoplastic (small cell lung cancer)
0,314  0,015  Neurotrophic factor enhancer
0,334  0,039  Mutagenic
0,350  0,057  Antineoplastic (ovarian cancer)
0,318  0,027  UGT1A4 substrate
0,335  0,047  Sensitization
0,296  0,008  LDLR expression enhancer
0,298  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,345  0,058  5 Hydroxytryptamine release stimulant
0,334  0,047  Antineoplastic (osteosarcoma)
0,297  0,012  Nitric-oxide synthase stimulant
0,306  0,024  VCAM1 expression inhibitor
0,298  0,019  Protein-tyrosine phosphatase inhibitor
0,323  0,049  Antipyretic
0,321  0,051  CYP1A2 inhibitor
0,330  0,066  CYP2D6 substrate
0,351  0,090  Antipruritic, allergic
0,338  0,078  Antiprotozoal (Plasmodium)
0,269  0,010  Xanthine oxidase inhibitor
0,339  0,082  CYP3A4 substrate
0,289  0,034  Antihypotensive
0,267  0,015  Alkylator
0,269  0,025  Insulin sensitizer
0,340  0,097  Antiprotozoal
0,242  0,005  Aldose reductase inhibitor
0,269  0,032  Pneumotoxic
0,244  0,011  SULT1A1 substrate
0,244  0,022  UGT2B9 substrate
0,315  0,099  Ulceration
0,228  0,015  Endometrios treatment
0,274  0,065  Antineoplastic (renal cancer)
0,244  0,037  Prostatic (benign) hyperplasia treatment
0,229  0,024  VEGF expression inhibitor
0,209  0,009  Dopamine agonist
0,207  0,008  Prolactin inhibitor
0,208  0,012  Histidine decarboxylase inhibitor
0,217  0,021  Gout treatment
0,223  0,031  Tubulin antagonist
0,272  0,079  Lipoprotein disorders treatment
0,271  0,080  Antihypoxic
0,200  0,010  Multidrug resistance-associated protein 1 inhibitor
0,297  0,109  CYP2C9 substrate
0,285  0,101  Vasodilator, coronary
0,250  0,068  Antineoplastic (sarcoma)
0,256  0,075  Antineoplastic (non-small cell lung cancer)
0,186  0,008  SULT1E1 substrate
0,248  0,073  Antineoplastic (liver cancer)
0,199  0,027  Cholesterol synthesis inhibitor
0,214  0,050  Antiviral (Hepatitis)
0,197  0,036  Carcinogenic, group 1
0,176  0,018  Antineoplastic (uterine cancer)
0,177  0,020  Carbonic anhydrase III inhibitor
0,166  0,011  Aromatase inhibitor
0,175  0,021  Gastritis treatment
0,195  0,043  Protein kinase stimulant
0,196  0,044  Antiviral (Hepatitis C)
0,158  0,009  Lipase inhibitor
0,170  0,020  Papain-like protease (SARS coronavirus) inhibitor
0,250  0,104  Metabolic disease treatment
0,160  0,016  NAD(P)H dehydrogenase (quinone) inhibitor
0,191  0,047  Antineoplastic (carcinoma)
0,160  0,021  Beta glucuronidase inhibitor
0,164  0,025  Contraceptive female
0,164  0,026  Carbonic anhydrase XV inhibitor
0,186  0,049  UGT2B10 substrate
0,146  0,012  Antiprotozoal activity enhancer
0,155  0,024  Protein kinase C mu inhibitor
0,201  0,071  Abortion inducer
0,197  0,070  CYP2B6 inhibitor
0,143  0,018  Opioid kappa receptor antagonist
0,186  0,062  Succinate dehydrogenase inhibitor
0,199  0,075  Antiviral (Influenza)
0,164  0,042  DNA polymerase I inhibitor
0,129  0,012  Alpha tubulin antagonist
0,166  0,049  Cyclooxygenase 1 inhibitor
0,142  0,026  DOPA decarboxylase inhibitor
0,190  0,074  Carcinogenic
0,126  0,011  SULT1A2 substrate
0,166  0,053  MAO inhibitor
0,161  0,048  NADPH oxidase inhibitor
0,205  0,092  RNA-directed DNA polymerase inhibitor
0,131  0,018  Keratolytic
0,252  0,140  GST A substrate
0,143  0,032  Antineoplastic antibiotic
0,115  0,004  Postcoital contraceptive
0,176  0,066  Toxic, respiratory center
0,202  0,092  Hypolipemic
0,168  0,059  Interferon gamma antagonist
0,112  0,004  Dopamine D5 agonist
0,134  0,027  Androgen antagonist
0,124  0,019  Dopamine D1 antagonist
0,154  0,050  M18 aspartyl aminopeptidase inhibitor
0,130  0,026  UGT2B11 substrate
0,134  0,031  Electron transport complex I inhibitor
0,150  0,048  Cyclooxygenase 3 inhibitor
0,116  0,014  Narcotic antagonist
0,133  0,032  Alpha 2 adrenoreceptor antagonist
0,130  0,030  Carcinogenic, group 2A
0,168  0,070  Antihelmintic (Nematodes)
0,130  0,032  Opioid antagonist
0,112  0,016  Adrenaline uptake inhibitor
0,159  0,063  Cyclooxygenase inhibitor
0,157  0,064  Antidiarrheal
0,122  0,029  Carbonic anhydrase VI inhibitor
0,112  0,020  Antiviral (Hepatitis A)
0,137  0,046  Microtubule formation inhibitor
0,112  0,021  Histone deacetylase stimulant
0,112  0,021  Histone deacetylase SIRT1 stimulant
0,125  0,035  Anabolic
0,188  0,098  Antialcoholic
0,171  0,082  Antipruritic, non-allergic
0,142  0,054  Antihelmintic (Trematoda)
0,130  0,043  Alpha 2c adrenoreceptor antagonist
0,092  0,013  SULT2A1 substrate
0,089  0,010  Dopamine D5 antagonist
0,187  0,109  Antineoplastic (lymphocytic leukemia)
0,146  0,070  Adenylate cyclase stimulant
0,141  0,065  Psychosexual dysfunction treatment
0,124  0,048  MAO B inhibitor
0,087  0,012  Transcription factor RelA inhibitor
0,125  0,050  MAO A inhibitor
0,099  0,024  Ca(v)3.1 blocker
0,128  0,053  Antiviral (Influenza B)
0,141  0,067  Antifungal enhancer
0,155  0,082  Arachidonic acid antagonist
0,166  0,093  Antirickettsial
0,141  0,069  Ca2+-transporting ATPase inhibitor
0,086  0,015  Fatty acid synthase inhibitor
0,082  0,013  Topoisomerase II beta inhibitor
0,134  0,066  Interleukin 4 antagonist
0,127  0,060  Beta amyloid protein antagonist
0,088  0,021  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,069  0,003  Toll-Like receptor 4 agonist
0,087  0,020  Glutamate (mGluR7) antagonist
0,070  0,004  Dopamine D1 agonist
0,101  0,036  Alpha 2a adrenoreceptor antagonist
0,178  0,113  Cyclic AMP phosphodiesterase inhibitor
0,191  0,128  Antiprotozoal (Trypanosoma)
0,077  0,014  Estradiol 17 beta-dehydrogenase inhibitor
0,160  0,098  Antihelmintic
0,159  0,098  Antineoplastic (bone cancer)
0,221  0,161  Sodium/bile acid cotransporter inhibitor
0,117  0,057  Mucolytic
0,122  0,063  Antitussive
0,170  0,111  Teratogen
0,182  0,123  Cardiovascular analeptic
0,076  0,018  Dopamine transporter inhibitor
0,070  0,012  Kinesin-like protein 1 inhibitor
0,070  0,012  Kinesin antagonist
0,093  0,038  Na+ K+ transporting ATPase inhibitor
0,093  0,039  Macrophage migration inhibitory factor inhibitor
0,057  0,004  Estrogen-related receptor beta antagonist
0,106  0,055  Dementia treatment
0,069  0,018  Dopamine D2 agonist
0,097  0,047  Ornithine decarboxylase inhibitor
0,108  0,058  Toll-Like receptor 4 antagonist
0,139  0,090  GABA C receptor rho-2 antagonist
0,063  0,014  Progesterone antagonist
0,124  0,076  Cyclooxygenase 2 inhibitor
0,144  0,097  Prostate disorders treatment
0,102  0,055  Vascular dementia treatment
0,058  0,012  Glucocorticoid antagonist
0,159  0,113  Embryotoxic
0,178  0,134  Immunostimulant
0,078  0,035  HIV-1 integrase (3'-Processing) inhibitor
0,104  0,061  5-Lipoxygenase inhibitor
0,075  0,032  Beta tubulin antagonist
0,209  0,166  Vasodilator, peripheral
0,072  0,032  Neuraminidase inhibitor
0,060  0,020  Squalene epoxidase inhibitor
0,095  0,057  Protein kinase C zeta inhibitor
0,070  0,031  Xanthine dehydrogenase inhibitor
0,161  0,123  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,052  0,015  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,106  0,069  GABA C receptor antagonist
0,182  0,146  Analeptic
0,136  0,103  CF transmembrane conductance regulator agonist
0,092  0,062  Uric acid excretion stimulant
0,218  0,189  Antiobesity
0,045  0,016  Cholesterol absorption inhibitor
0,084  0,056  D-Ala-D-Ala ligase inhibitor
0,098  0,071  Expectorant
0,088  0,063  Actinic keratosis treatment
0,183  0,158  Radiosensitizer
0,090  0,065  HIV-1 integrase (Overall Integration) inhibitor
0,096  0,072  Urease inhibitor
0,083  0,059  Estrogen-related receptor beta agonist
0,108  0,085  Constipation treatment
0,058  0,035  Protein kinase C eta inhibitor
0,085  0,064  Sodium/hydrogen exchanger 5 inhibitor
0,037  0,017  Nucleoside transporters inhibitor
0,174  0,155  Respiratory analeptic
0,140  0,121  Diabetic nephropathy treatment
0,031  0,012  Sodium/glucose cotransporter 2 inhibitor
0,046  0,027  Opioid kappa receptor agonist
0,059  0,042  HIV-1 integrase (Strand Transfer) inhibitor
0,029  0,012  Sodium/glucose cotransporter inhibitor
0,062  0,046  Glucagon-like peptide 1 agonist
0,021  0,006  NMDA receptor phencyclidine site antagonist
0,027  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,142  0,128  Angiogenesis stimulant
0,180  0,166  Antidepressant
0,062  0,049  Neuraminidase (influenza) inhibitor
0,073  0,060  Antitreponemal
0,037  0,026  Glucose-6-phosphate dehydrogenase inhibitor
0,147  0,136  Antiparasitic
0,054  0,044  Dopamine uptake inhibitor
0,069  0,059  Carbonic anhydrase XIII inhibitor
0,062  0,053  Alpha adrenoreceptor agonist
0,118  0,109  Antiviral (Influenza A)
0,037  0,030  Dopamine D3 agonist
0,079  0,072  Antiadrenergic
0,060  0,054  Opioid mu receptor antagonist
0,156  0,150  Tumour necrosis factor alpha release inhibitor
0,021  0,016  Estrone sulfatase inhibitor
0,077  0,071  Adrenaline antagonist
0,135  0,130  Lipocortins synthesis antagonist
0,116  0,111  Antidote
0,043  0,038  Antibiotic Glycopeptide-like
0,153  0,149  Antineoplastic enhancer
0,023  0,019  Sodium/glucose cotransporter 1 inhibitor
0,049  0,045  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,056  0,053  Transcription factor AP-1 inhibitor
0,149  0,147  Antineoplastic (lymphoma)
0,201  0,198  FMO1 substrate
0,053  0,051  Opioid delta receptor antagonist
0,046  0,044  Opioid agonist
0,177  0,176  12-Lipoxygenase inhibitor
0,016  0,014  Progesterone agonist
0,031  0,030  HMG CoA reductase inhibitor

